Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Metabolic remodeling in chronic heart failure.

Wang J, Guo T.

J Zhejiang Univ Sci B. 2013 Aug;14(8):688-95. doi: 10.1631/jzus.B1300137. Review.

2.

[Metabolic therapy for heart failure].

Loiacono F, Alberti L, Lauretta L, Puccetti P, Silipigni C, Margonato A, Fragasso G.

Recenti Prog Med. 2014 Jul-Aug;105(7-8):288-94. doi: 10.1701/1574.17114. Review. Italian.

PMID:
25072544
3.

Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure.

Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Soga T, Kita T, Kimura T, Shioi T.

Circ Heart Fail. 2010 May;3(3):420-30. doi: 10.1161/CIRCHEARTFAILURE.109.888479. Epub 2010 Feb 22.

4.

Metabolic remodelling of the failing heart: beneficial or detrimental?

van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ.

Cardiovasc Res. 2009 Feb 15;81(3):420-8. doi: 10.1093/cvr/cvn282. Epub 2008 Oct 14. Review.

PMID:
18854380
5.

Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.

Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.

Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20. Review.

6.

Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.

Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.

Heart. 2011 Sep;97(18):1495-500. doi: 10.1136/hrt.2011.226332. Epub 2011 Jun 23.

PMID:
21700755
7.

Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.

Fukushima A, Milner K, Gupta A, Lopaschuk GD.

Curr Pharm Des. 2015;21(25):3654-64. Review.

PMID:
26166604
8.

Metabolic therapy of heart failure.

Fragasso G, Salerno A, Spoladore R, Bassanelli G, Arioli F, Margonato A.

Curr Pharm Des. 2008;14(25):2582-91. Review.

PMID:
18991675
9.

Modulating fatty acid oxidation in heart failure.

Lionetti V, Stanley WC, Recchia FA.

Cardiovasc Res. 2011 May 1;90(2):202-9. doi: 10.1093/cvr/cvr038. Epub 2011 Feb 2. Review.

10.

Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.

Lopaschuk GD.

Semin Cardiothorac Vasc Anesth. 2006 Sep;10(3):228-30.

PMID:
16959756
11.

Prognostic relevance of metabolic approach in patients with heart failure.

Di Napoli P, Barsotti A.

Curr Pharm Des. 2009;15(8):883-92. Review.

PMID:
19275652
12.

Metabolic modulation and optimization of energy consumption in heart failure.

Ferrari R, Cicchitelli G, Merli E, Andreadou I, Guardigli G.

Med Clin North Am. 2003 Mar;87(2):493-507, xii-xiii. Review.

PMID:
12693736
13.

Myocardial fatty acid metabolism and cardiac performance in heart failure.

Tuunanen H, Ukkonen H, Knuuti J.

Curr Cardiol Rep. 2008 Mar;10(2):142-8. Review.

PMID:
18417015
14.

Optimization of cardiac metabolism in heart failure.

Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S.

Curr Pharm Des. 2011 Dec;17(35):3846-53. Review.

15.
16.

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.

Rupp H, Zarain-Herzberg A, Maisch B.

Herz. 2002 Nov;27(7):621-36. Review.

PMID:
12439634
17.

Energy metabolism in cardiac remodeling and heart failure.

Azevedo PS, Minicucci MF, Santos PP, Paiva SA, Zornoff LA.

Cardiol Rev. 2013 May-Jun;21(3):135-40. doi: 10.1097/CRD.0b013e318274956d. Review.

PMID:
22990373
18.

The heart metabolism: pathophysiological aspects in ischaemia and heart failure.

Abozguia K, Shivu GN, Ahmed I, Phan TT, Frenneaux MP.

Curr Pharm Des. 2009;15(8):827-35. Review.

PMID:
19275646
19.

Role of metabolically active drugs in the management of ischemic heart disease.

Schofield RS, Hill JA.

Am J Cardiovasc Drugs. 2001;1(1):23-35. Review.

PMID:
14728049
20.

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ.

Cardiovasc Res. 2004 Feb 1;61(2):218-26. Review.

PMID:
14736538

Supplemental Content

Support Center